Evidence map›Paper›PMID 40244270›Full record

ArticleInternational journal of molecular sciences2025

Association of Intergenic and Intragenic

Katharina Pühringer, Philipp Czarda, Sebastian Iluca, Katja Zappe, Serge Weis, Sabine Spiegl-Kreinecker, Margit Cichna-Markl

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Cells · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katharina PühringerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0009-0005-6187-6641
Philipp CzardaDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0009-0005-5965-5911
Sebastian IlucaDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
Katja ZappeDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-2002-9727
Serge WeisDivision of Neuropathology, Department of Pathology and Molecular Pathology, Kepler University Hospital GmbH, Johannes Kepler University, 4040 Linz, Austria.ORCID 0000-0001-6750-2599
Sabine Spiegl-KreineckerClinical Research Institute for Neurosciences, Johannes Kepler University, 4020 Linz, Austria.
Margit Cichna-MarklDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-8699-674X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The methylation status of the

Indexed as

Brain NeoplasmsDNA MethylationDNA Modification MethylasesDNA Repair EnzymesEnhancer Elements, GeneticGlioblastomaPromoter Regions, GeneticTumor Suppressor ProteinsAdultAgedCpG IslandsFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedDNA Modification MethylasesDNA Repair EnzymesMGMT protein, humanTumor Suppressor Proteinsenhancer methylationglioblastomaintergenic enhancerintragenic enhancerMGMToverall survivalprognostic biomarkerpyrosequencing

Identifiers

PMID40244270
PMCPMC11990025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.